2017
DOI: 10.1016/s2214-109x(17)30345-5
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis D virus in Africa: several unmet needs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 10 publications
0
7
0
Order By: Relevance
“…The reasons for this huge variation in HDV prevalence between regions (and between countries within a given region) are unknown. Unmet needs include a better description of the epidemiology of the virus, its natural history and the modes of transmission in Africa 4 5. Demographic Health Surveys (DHS) offer a unique opportunity for the mapping of various pathogens on a very large nationwide representative sample.…”
Section: Introductionmentioning
confidence: 99%
“…The reasons for this huge variation in HDV prevalence between regions (and between countries within a given region) are unknown. Unmet needs include a better description of the epidemiology of the virus, its natural history and the modes of transmission in Africa 4 5. Demographic Health Surveys (DHS) offer a unique opportunity for the mapping of various pathogens on a very large nationwide representative sample.…”
Section: Introductionmentioning
confidence: 99%
“…HDV infection is restricted to co-infection with hepatitis B virus (HBV) or superinfection of HBV-infected individuals due to the requirement for HBV surface antigen (HBsAg) in the HDV viral envelope. An estimated 15–20 million people are co-infected with HBV and HDV worldwide; with areas of high endemicity in the Middle East, the Amazonian region of South America, the Mediterranean, and western and central Africa 1 . The impact of HDV infection is substantial: co-infection results in a more severe clinical outcome than HBV alone, while superinfection of HBV infected patients with HDV results in greater probability of chronic infection, more rapid progression to cirrhosis 2 , and overall greater risk of morbidity 3 .…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, HDV inhibits HBV replication, lowering HBV DNA levels detectable in patient blood 6 8 , and thereby potentially complicating HBV patient management. The ability to detect and monitor for HDV is clearly critical to patient care and the need for novel therapeutics is imperative 9 12 , especially in regions of elevated HDV prevalence 1 , 13 .…”
Section: Introductionmentioning
confidence: 99%
“…Various therapeutic targets in hepatitis D virus infection, including prenylation, viral entry, and HBsAg secretion, are under investigation, but these drugs all are in early clinical development. Regulatory authorities such as the European Medicines Agency classify hepatitis D virus infection as an orphan disease and have given orphan drug status to novel therapies (Manns, 2017).…”
Section: Literaturementioning
confidence: 99%
“…Particularly severe forms of hepatitis D virus infection were reported in the Amazon Basin, where the combination of hepatitis D virus genotype 3 with hepatitis B virus genotype F is prevalent. The natural course of hepatitis D virus infection and disease phenotype depend on host, virus, and environmental factors (Manns, 2017). In The Lancet Global Health, Alexander Stockdale and colleagues did a systematic review and meta-analysis to assess anti-hepatitis D virus seroprevalence in HBsAg-positive patients in sub-Saharan Africa.…”
Section: Literaturementioning
confidence: 99%